Showing 12,161 - 12,180 results of 65,375 for search '(( 50 ms decrease ) OR ( 5 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.09s Refine Results
  1. 12161

    Table_2_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  2. 12162

    Table_1_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  3. 12163

    Image_9_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  4. 12164

    Image_3_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  5. 12165

    Image_8_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  6. 12166

    Table_6_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  7. 12167
  8. 12168

    Image_7_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.TIF by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  9. 12169

    Table_4_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  10. 12170

    Image_5_High Dose Vitamin D3 Supplementation Is Not Associated With Lower Mortality in Critically Ill Patients: A Meta-Analysis of Randomized Control Trials.pdf by Zhiwei Gao (686378)

    Published 2022
    “…The use of a high dose of vitamin D3 in critically ill patients could not decrease the mortality truncated to day 28 (RR 0.93, 95% CI 0.78–1.11, P = 0.43) or day 90 (RR 0.91, 95% CI 0.79–1.05, P = 0.21). …”
  11. 12171

    Table_8_A cross-sectional study on the nasopharyngeal microbiota of individuals with SARS-CoV-2 infection across three COVID-19 waves in India.XLSX by Tungadri Bose (680564)

    Published 2023
    “…In general, we observed a decrease in the burden of opportunistic pathogens in the host microbiota during the later waves of infection.…”
  12. 12172
  13. 12173
  14. 12174
  15. 12175
  16. 12176

    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... by Lívia Pimenta Bonifácio (7502579)

    Published 2023
    “…The primary outcome was accessed in the “per protocol” population as the proportion of patients with clinical improvement, defined as a decrease greater or equal to two points on the World Health Organization’s (WHO) seven-category ordinal scale by day 28. …”
  17. 12177

    Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last? by Aygul Tantik PAK (12686251)

    Published 2022
    “…The mean analgesic intake before BoNTA was 11.48±4.68 tablets/month, while it decreased to 6.53±2.72 tablets/month in the first month (p<0.001) and 5.40±2.46 tablets/month in the second month (p<0.001). …”
  18. 12178
  19. 12179
  20. 12180